IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2041-1723
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells ; volume:9 ; number:1 ; day:31 ; month:1 ; year:2018 ; pages:1-15 ; date:12.2018
Nature Communications ; 9, Heft 1 (31.1.2018), 1-15, 12.2018
- Urheber
-
Hsieh, Wan-Chen
- Beteiligte Personen und Organisationen
-
Hsu, Tzu-Sheng
Chang, Ya-Jen
Lai, Ming-Zong
SpringerLink (Online service)
- DOI
-
10.1038/s41467-018-02862-4
- URN
-
urn:nbn:de:101:1-2018090702510489795155
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:26 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hsieh, Wan-Chen
- Hsu, Tzu-Sheng
- Chang, Ya-Jen
- Lai, Ming-Zong
- SpringerLink (Online service)
Ähnliche Objekte (12)
Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflammatory bowel disease
JAKi Salvage Therapy Followed by Curative Cord Blood Transplantation in a XIAP-Deficient Infant with Relapsing HLH
JAKi salvage therapy followed by curative cord blood transplantation in a XIAP-deficient infant with relapsing HLH
Röntgenstrukturanalyse der Caspase-3-XIAP-BIR2-, Caspase-7-XIAP-BIR2-Komplexe und der Procaspase-7
Röntgenstrukturanalyse der Caspase-3-XIAP-BIR2, Caspase-7-XIAP-BIR2-Komplexe und der Procaspase-7
SMAC dependency of XIAP mediated chemoresistance
SMAC dependency of XIAP mediated chemoresistance
XIAP Confers Immunity Against Intracellular Bacteria
Concentration of Point Defects in Metal Deficient Zn 1-y O
Ubiquitin-dependent regulation of Cdc42 by XIAP
Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1
Apoptosis-unrelated functions of XIAP during melanoma development
Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflammatory bowel disease
JAKi Salvage Therapy Followed by Curative Cord Blood Transplantation in a XIAP-Deficient Infant with Relapsing HLH
JAKi salvage therapy followed by curative cord blood transplantation in a XIAP-deficient infant with relapsing HLH
Röntgenstrukturanalyse der Caspase-3-XIAP-BIR2-, Caspase-7-XIAP-BIR2-Komplexe und der Procaspase-7
Röntgenstrukturanalyse der Caspase-3-XIAP-BIR2, Caspase-7-XIAP-BIR2-Komplexe und der Procaspase-7
SMAC dependency of XIAP mediated chemoresistance
SMAC dependency of XIAP mediated chemoresistance
XIAP Confers Immunity Against Intracellular Bacteria
Concentration of Point Defects in Metal Deficient Zn 1-y O
Ubiquitin-dependent regulation of Cdc42 by XIAP
Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1
Apoptosis-unrelated functions of XIAP during melanoma development
Understanding the molecular mechanism of pathogenic variants of BIR2 domain in XIAP-deficient inflammatory bowel disease
JAKi Salvage Therapy Followed by Curative Cord Blood Transplantation in a XIAP-Deficient Infant with Relapsing HLH
JAKi salvage therapy followed by curative cord blood transplantation in a XIAP-deficient infant with relapsing HLH
Röntgenstrukturanalyse der Caspase-3-XIAP-BIR2-, Caspase-7-XIAP-BIR2-Komplexe und der Procaspase-7
Röntgenstrukturanalyse der Caspase-3-XIAP-BIR2, Caspase-7-XIAP-BIR2-Komplexe und der Procaspase-7
SMAC dependency of XIAP mediated chemoresistance
SMAC dependency of XIAP mediated chemoresistance
XIAP Confers Immunity Against Intracellular Bacteria
Concentration of Point Defects in Metal Deficient Zn 1-y O
Ubiquitin-dependent regulation of Cdc42 by XIAP
Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1